Pharmaceutical Contract Manufacturing Market Share Analysis, Strategies, Revenue and Forecasts to 2023

Posted August 26, 2019 by diksha3847

The global pharmaceutical contract manufacturing market is expecting a rapid change which would take place with a 7.2% CAGR during the forecast period (2017-2023).
Competitive Landscape:

The intensely competitive market has several players that are impacting the global pharmaceutical contract manufacturing market by implementing strategic moves. These players, as per MRFR report, are


Boehringer Ingelheim

Lonza AG

Grifols International S.A

AbbVie Inc

Patheon Inc.


Pharmaceutical Product Development and others.


Pharmaceutical Contract Manufacturing Market Overview:

The global pharmaceutical contract manufacturing market is expecting a rapid change which would take place with a 7.2% CAGR during the forecast period (2017-2023). Market Research Future (MRFR) in their latest report on the same discussed the possibility of a demographic change in the market due to the pipelining of project and pricing pressures. The pharmaceutical industry needs to adapt to the competitive scenario where shedding some burden by providing opportunities to pharmaceutical contract manufacturing companies who provide excellence would be beneficial for them. This would help in retaining customers and expansion plans for the future.

Over the years, the need for effective drugs is growing, and pharmaceutical companies are finding it difficult to stay up to the mark. At the same time, a lot of drugs are going off the list and lot are in the process of getting FDA approval due to which the pressure is substantial. The pharmaceutical contract manufacturing market is all set to gain from this as a lot of production would be offered to these companies to meet the requirement. Mushrooming startups are going to boost the market further. At the same time, a considerable rise in the biological therapies can provide the pharmaceutical contract manufacturing market with opportunities that can take the market ahead.

On the other hand, Lack of manufacturing standardization and logistics issues could play spoilsport during the forecast period. The expected returns can be daunted further by increasing lead time.

Segmental Analysis:

MRFR only analyzes the global pharmaceutical contract manufacturing market based on the type. The segmentation includes both volume-wise and value-wise data for a better understanding of the entire market.

Based on the mode of type, the global pharmaceutical contract manufacturing market can be segmented into active pharmaceutical ingredient manufacturing, finished dosage formulation market, and others. The active pharmaceutical ingredient manufacturing segment has the charge in the restructuring of the pharmaceutical industry.

Industry Updates:

In April 2017, I-Mab Biopharma (I-Mab), based out of Shanghai, and Jiangsu Nhwa Pharmaceutical, a company with special focus on the development of drugs for the central nervous system. They have declared their partnership with Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital and Biodextris. The aim is to develop immune-stimulatory therapy through pharmaceutical contract manufacturing.

Regional Analysis:

Superior technology, astounding healthcare structure, high investment capacity, and better reimbursement ratios are some factors that are giving the Americas an edge over the rest in the global market owing to which the region is dominating global sphere. Major players operating from the region is also a substantial boost for the market.

Europe ranks second in the pharmaceutical contract manufacturing market. The regional market is thriving on the support provided by governments in the region. The research & development that is taking place is of a superior kind. It is also fetching a substantial amount of money by developing drugs of better class.


The APAC is expected to rise with the fastest CAGR during the forecast period. Improving technology, and regional development as a probable market opportunity are making it alluring for many western investors.

The MEA market’s development is not up to the par and is expected to project poor growth opportunities. The regional market is getting daunted by the presence of poor and slow developing countries, especially, in the African region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By [email protected]
Phone 6468459312
Business Address Office No. 528, Amanora Chambers, , Magarpatta Road, Hadapsar,,
Country India
Categories Health
Last Updated August 26, 2019